Quick Takeaways
- Benjamin R. Yerxa has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,749,903.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Benjamin R. Yerxa
- Location
- Durham, NC
- Summary
- The estimated net worth of Benjamin R. Yerxa is at least $3,749,903 dollars as of 27 Apr 2026. Benjamin R. Yerxa is the President, Director of Opus Genetics, Inc. and owns shares of Opus Genetics, Inc. (IRD) stock worth about $3.73M. Benjamin R. Yerxa is the Director of Clearside Biomedical, Inc. and owns shares of Clearside Biomedical, Inc. (CLSDQ) stock worth about $23.5K.
- Signature
- /s/ Amy Rabourn, by Power of Attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Benjamin R. Yerxa and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Opus Genetics, Inc. ($3,726,379).
- Past-year value change for that position: -$39,121.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Benjamin R. Yerxa
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | President, Director | $3,726,379 | -$39,121 | -1% | 23 Apr 2026 |
| CLSDQ | Clearside Biomedical, Inc. | Director | $23,524 | 20 Jun 2024 |
Insider Transactions Reported by Benjamin R. Yerxa:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.